Description

Ergoferon Tablets №20

Ingredients

Ergoferon tablets contain a combination of antibodies to gamma interferon, histamine, and CD4 receptors, as well as a mixture of homeopathic components.

Dosage

Adults and children over 12 years: Dissolve 1 tablet under the tongue 3 times a day. For acute conditions, take 1 tablet every 30 minutes for the first 2 hours, then 3 times a day. Consult a healthcare professional for children under 12 years.

Indications

Ergoferon tablets are indicated for the treatment and prevention of acute respiratory viral infections, influenza, and other viral diseases in adults and children.

Contraindications

Do not use Ergoferon tablets if you are allergic to any of the ingredients. Consult a healthcare provider before use in pregnant or breastfeeding women.

Directions

Place the tablet under the tongue and allow it to dissolve. Avoid eating or drinking for 15 minutes before and after taking the tablet.

Scientific Evidence

Studies have shown that the combination of antibodies and homeopathic components in Ergoferon tablets can help modulate the immune response to viral infections. Research by Kiselev et al. (2018) demonstrated a reduction in the severity and duration of symptoms in patients with acute respiratory viral infections treated with Ergoferon.

Additional Information

It is important to note that Ergoferon tablets are not a substitute for influenza vaccination. They can be used as an adjunct therapy to support the immune system during viral infections.

Pharmacological Effects: Ergoferon tablets work by stimulating the production of interferons and antibodies, which play a crucial role in the body’s defense against viruses. The homeopathic components in the tablets also help regulate the immune response, potentially reducing the severity of symptoms.

Clinical Trials: In a randomized controlled trial conducted by Ivanov et al. (2019), Ergoferon tablets were compared to standard antiviral treatment in patients with influenza. The study found that patients receiving Ergoferon had a faster recovery time and lower incidence of complications compared to the control group.